Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus
- PMID: 9302218
- PMCID: PMC170612
- DOI: 10.1128/cdli.4.5.624-626.1997
Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus
Abstract
A 10 mM concentration of lithium does not interfere with reverse transcription (RT) or PCR. Sampling of cervicovaginal fluid by vaginal washing, with lithium (10 mM) in the washing buffer as a marker of dilution, may be utilized to accurately determine in HIV-infected women, by quantitative RT-PCR, the genital shedding of acellular HIV RNA at the level of the mucosa itself.
Similar articles
-
Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.Obstet Gynecol. 2001 Jun;97(6):999-1004. doi: 10.1016/s0029-7844(01)01130-9. Obstet Gynecol. 2001. PMID: 11384710
-
Cell-associated, non-replicating strand(+) hepatitis C virus-RNA shedding in cervicovaginal secretions from chronically HCV-infected women.J Clin Virol. 2003 Aug;27(3):247-51. doi: 10.1016/s1386-6532(02)00178-6. J Clin Virol. 2003. PMID: 12878088
-
Comparison of washing and swabbing procedures for collecting genital fluids to assess shedding of human immunodeficiency virus type 1 (HIV-1) RNA in asymptomatic HIV-1-infected women.J Clin Microbiol. 2003 Jan;41(1):449-52. doi: 10.1128/JCM.41.1.449-452.2003. J Clin Microbiol. 2003. PMID: 12517891 Free PMC article.
-
The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.Am J Obstet Gynecol. 2005 Mar;192(3):774-9. doi: 10.1016/j.ajog.2004.10.609. Am J Obstet Gynecol. 2005. PMID: 15746671
-
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):91-6. doi: 10.1007/s100960000442. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11305478
Cited by
-
Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.PLoS One. 2018 Apr 27;13(4):e0196397. doi: 10.1371/journal.pone.0196397. eCollection 2018. PLoS One. 2018. PMID: 29702672 Free PMC article. Clinical Trial.
-
Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.AIDS Res Hum Retroviruses. 2008 May;24(5):667-71. doi: 10.1089/aid.2007.0268. AIDS Res Hum Retroviruses. 2008. PMID: 18462081 Free PMC article.
-
Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.AIDS Res Hum Retroviruses. 2011 Jan;27(1):35-9. doi: 10.1089/aid.2010.0129. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2011. PMID: 20929397 Free PMC article.
-
MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments.PLoS One. 2013;8(1):e55013. doi: 10.1371/journal.pone.0055013. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383037 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical